85 related articles for article (PubMed ID: 15069107)
21. Stem cell divisions controlled by the proto-oncogene BMI-1.
Grinstein E; Mahotka C
J Stem Cells; 2009; 4(3):141-6. PubMed ID: 20232599
[TBL] [Abstract][Full Text] [Related]
22. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia.
Bhattacharyya J; Mihara K; Yasunaga S; Tanaka H; Hoshi M; Takihara Y; Kimura A
Ann Hematol; 2009 Apr; 88(4):333-40. PubMed ID: 18781299
[TBL] [Abstract][Full Text] [Related]
23. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.
Warner JK; Wang JC; Takenaka K; Doulatov S; McKenzie JL; Harrington L; Dick JE
Leukemia; 2005 Oct; 19(10):1794-805. PubMed ID: 16094415
[TBL] [Abstract][Full Text] [Related]
24. Bmi1, stem cells, and senescence regulation.
Park IK; Morrison SJ; Clarke MF
J Clin Invest; 2004 Jan; 113(2):175-9. PubMed ID: 14722607
[TBL] [Abstract][Full Text] [Related]
25. Stem cells and cancer; the polycomb connection.
Valk-Lingbeek ME; Bruggeman SW; van Lohuizen M
Cell; 2004 Aug; 118(4):409-18. PubMed ID: 15315754
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
27. BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia.
Larmonie NS; Dik WA; Beverloo HB; van Wering ER; van Dongen JJ; Langerak AW
Leukemia; 2008 Jun; 22(6):1266-7. PubMed ID: 17989714
[No Abstract] [Full Text] [Related]
28. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
Siddique HR; Saleem M
Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
[TBL] [Abstract][Full Text] [Related]
29. [Stem cell and cancer in bile epithelial cells].
Taniguchi H; Chiba T
Nihon Rinsho; 2006 Jan; 64 Suppl 1():348-53. PubMed ID: 16457280
[No Abstract] [Full Text] [Related]
30. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors.
Pardal R; Molofsky AV; He S; Morrison SJ
Cold Spring Harb Symp Quant Biol; 2005; 70():177-85. PubMed ID: 16869752
[TBL] [Abstract][Full Text] [Related]
31. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park IK; Qian D; Kiel M; Becker MW; Pihalja M; Weissman IL; Morrison SJ; Clarke MF
Nature; 2003 May; 423(6937):302-5. PubMed ID: 12714971
[TBL] [Abstract][Full Text] [Related]
32. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.
Yang J; Chai L; Liu F; Fink LM; Lin P; Silberstein LE; Amin HM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10494-9. PubMed ID: 17557835
[TBL] [Abstract][Full Text] [Related]
33. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
[TBL] [Abstract][Full Text] [Related]
34. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
35. Correspondence re: S. Beá et al., BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res., 61: 2409-2412, 2001.
Raaphorst FM; Meijer CJ; Otte AP
Cancer Res; 2002 Jan; 62(2):618-9. PubMed ID: 11809719
[No Abstract] [Full Text] [Related]
36. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.
Sawa M; Yamamoto K; Yokozawa T; Kiyoi H; Hishida A; Kajiguchi T; Seto M; Kohno A; Kitamura K; Itoh Y; Asou N; Hamajima N; Emi N; Naoe T
Int J Hematol; 2005 Jul; 82(1):42-7. PubMed ID: 16105758
[TBL] [Abstract][Full Text] [Related]
37. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
38. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.
Guo WJ; Zeng MS; Yadav A; Song LB; Guo BH; Band V; Dimri GP
Cancer Res; 2007 Jun; 67(11):5083-9. PubMed ID: 17545584
[TBL] [Abstract][Full Text] [Related]
39. Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.
Qian T; Lee JY; Park JH; Kim HJ; Kong G
Oncogene; 2010 Oct; 29(43):5818-27. PubMed ID: 20697353
[TBL] [Abstract][Full Text] [Related]
40. Adhesion-mediated self-renewal abilities of Ph+ blastoma cells.
Funayama K; Saito-Kurimoto Y; Ebihara Y; Shimane M; Nomura H; Tsuji K; Asano S
Biochem Biophys Res Commun; 2010 May; 396(2):193-8. PubMed ID: 20362549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
